EMR vs ITW: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. EMR and ITW share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined EMR and ITW exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Emerson Electric is a global industrial-technology company focused on automation, helping manufacturers and process industries run their plants more efficiently, safely, and reliably. Over the past several years Emerson has transformed itself from a diversified industrial conglomerate into a more focused automation pure-play, divesting legacy businesses like its commercial and residential climate-technologies unit and acquiring software and measurement assets. Its core products include process control systems, measurement and analytical instruments, valves and actuators, software for plant operations, and test and measurement equipment, much of it sold under brands like DeltaV, Rosemount, Fisher, AspenTech, and NI (National Instruments). Customers span energy, chemicals, life sciences, power, water, food and beverage, and discrete manufacturing. Emerson makes money by selling this hardware and software plus recurring service, software subscriptions, and aftermarket parts, with a meaningful share of revenue tied to keeping installed systems running. The shift toward higher-margin software and recurring revenue, anchored by its majority stake in AspenTech, is central to its strategy. Emerson is headquartered in St. Louis, Missouri.

Full EMR guide

Illinois Tool Works Inc. (NYSE: ITW) is a Glenview, Illinois-based diversified manufacturer founded in 1912 that makes engineered fasteners, components, equipment, and consumable systems for customers around the world. The company is organized into seven segments: Automotive OEM, Test & Measurement and Electronics, Food Equipment, Polymers & Fluids, Welding, Construction Products, and Specialty Products. Its defining feature is the 80/20 operating model, a discipline of focusing on the roughly 20% of products and customers that drive about 80% of value, which has produced some of the highest and most consistent operating margins in the industrial sector, near 26%. ITW competes largely on proprietary, patent-protected niche products embedded in customer processes, which gives it pricing power and sticky demand.

Full ITW guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• EMR drivers: Automation pure-play transformation; Software and recurring revenue.
• ITW drivers: Margin expansion from the 80/20 model; Diversified, niche-leading segments.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Emerson's end markets are cyclical and tied to industrial capital spending, energy and chemical capex, and the global economy, so downturns can slow orders and revenue. For ITW, iTW's end markets are mature and cyclical, so a downturn in global auto production, industrial capital spending, or construction activity would pressure organic sales, which already grow only in the low single digits.

Pick EMR if you believe its drivers more; ITW if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the EMR and ITW guides.

EMR. Emerson trades at a premium to the average industrial, reflecting its transformation into a higher-margin automation and software business and its anchor stake in AspenTech. The market values the recurring-revenue mix, margin expansion, and strong cash generation, while weighing acquisition and integration risk. Its Dividend King status and steady cash flow underpin a quality-industrial profile.

ITW. ITW is usually valued as a quality industrial compounder, so investors focus less on revenue growth and more on margins, free cash flow, return on invested capital, and per-share earnings growth. Its operating margin near 26% is among the highest in diversified industrials, and the forward price-to-earnings ratio in the low twenties reflects a premium the market assigns to that consistency and the long dividend record. Because organic growth is modest, the earnings-per-share story leans on margin expansion and buybacks, which is why guidance for about 7% EPS growth in 2026 comes alongside only 2 to 4% expected revenue growth.

Headline figures (approximate, early 2026): EMR shows revenue (ttm) ~$17-18 billion, operating margin ~20%+, expanding, revenue growth Mid-single-digit underlying, plus acquisitions, software and recurring mix Growing share of revenue; ITW shows revenue (fy2025) ~$16 billion, up ~0.9% YoY, operating margin (fy2025) ~26.3%, gaap eps (fy2025) ~$10.49, 2026 eps guidance ~$11.00 to $11.40 (up ~7% at midpoint).

EMR and ITW are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined EMR and ITW exposure against your real portfolio. It is not an investment adviser.